Evaxion A (EVAX) Operating Leases (2019 - 2025)
Evaxion A's (EVAX) quarterly Operating Leases came in at $2.0 million in Q4 2025, up 1.71% YoY from $1.9 million in Q4 2024, and up 14.89% on a QoQ basis from $1.7 million in Q2 2025.
Evaxion A (EVAX) Operating Leases (2019 - 2025) Analysis & Trends
Evaxion A (EVAX) has 7 years of Operating Leases data on file, last reported at $2.0 million in Q4 2025.
- Quarterly Operating Leases rose 1.71% year-over-year to $2.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.0 million (up 1.71% YoY) and the FY2025 annual result came in at $2.0 million, up 1.71% from the prior year.
- Operating Leases improved to $2.0 million in Q4 2025, from $1.7 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $2.5 million in Q4 2021 to a low of $974000.0 in Q2 2021.
- A 5-year average of $1.9 million and a median of $2.0 million in 2022 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2021 — Operating Leases soared 12500.0% — and 2024, when it retreated 12.96%.
- Tracing EVAX's Operating Leases over 5 years: stood at $2.5 million in 2021, then fell by 10.52% to $2.3 million in 2022, then fell by 1.46% to $2.2 million in 2023, then dropped by 12.96% to $1.9 million in 2024, then grew by 1.71% to $2.0 million in 2025.
- The last three Operating Leases figures came in at $2.0 million (Q4 2025), $1.7 million (Q2 2025), and $1.9 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.57 Bn | 130.72 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 77.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.00 Bn | 59.82 Bn | 1.37 Bn |
| 4 | Moderna | 56.27 Bn | 51.13 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.00 Bn | 36.90 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.68 Bn | 9.29 Bn | 668.28 Mn |
| 8 | Insmed | 27.43 Bn | 26.27 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.34 Bn | 26.51 Bn | - |
| 10 | Evaxion A | 27.69 Mn | 27.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.97 Mn |
| Jun 30, 2025 | 1.71 Mn |
| Dec 31, 2024 | 1.93 Mn |
| Jun 30, 2024 | 1.75 Mn |
| Dec 31, 2023 | 2.22 Mn |
| Jun 30, 2023 | 1.95 Mn |
| Dec 31, 2022 | 2.26 Mn |
| Jun 30, 2022 | 1.97 Mn |
| Mar 31, 2022 | 2.14 Mn |
| Dec 31, 2021 | 2.52 Mn |
| Sep 30, 2021 | 2.29 Mn |
| Jun 30, 2021 | 974,000.00 |
| Mar 31, 2021 | 1.05 Mn |
| Dec 31, 2020 | 20,000.00 |
| Dec 31, 2019 | 36,000.00 |